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Figure S6. LC-MS stability assay of cp. 3 in 10 mM MES pH 7.4 (10% methanol) at 22.5°C. Figure S7 . LC-MS stability assay of dithiocarbamate 21 in 10 mM Hepes pH 7.4 (10% methanol) at 22.5°C, illustrating that the dithiocarbamates are stable within the experimental time frame as no hydrolysis to the corresponding free thiol 13 occurs. Table S1 . Structure and activity of thiocarbamates and related compounds. Screening Library. The screening library comprising 1,520 low-molecular weight compounds was purchased from TimTec (Newark, DE, USA). The compounds had an average molecular weight (MW) of 390 Da and were provided as 10 mM stock solutions in DMSO. 
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ColH-PD to a final concentration of 2, 4, and 6 nM. The final reaction buffer contained 250 mM Hepes pH 7.5, 400 mM NaCl, 10 mM CaCl 2 , 10 µM ZnCl 2 , 2% DMSO, and 2.5 -120 µM substrate. Cleavage of the substrate was followed by measuring the fluorescence signal every 5 s for 2 min (Excitation: 328 nm, Emission: 392 nm) in an Infinite M200 plate reader (Tecan, Grödig, Austria)
at 25°C. The initial velocity was determined from the progress curves (<10% substrate conversion) using regression analysis 3 and inner filter effect-correction 4 . The ε ex328 and ε em392 were estimated in the buffer used for the kinetic assays to be 21794 M -1 cm -1
and 9561 M -1 cm -1 . K M and k cat were calculated by non-linear regression from the resulting Michaelis − Menten plot using GraphPad Prism 5 (Graph Pad Software, San Diego, CA, USA).
FRET-Based Inhibition Assay. In the secondary screening, ColH-PD was pretreated with the compounds for 1 h at room temperature. The reaction was initiated by the addition of 5 µM FS1-1. The increase in fluorescence was monitored for 2 min (Excitation: 328 nm, Emission: 392 nm) at 25°C. The final concentrations were 50 nM ColH-PD, 40 µM compound or isoamylphosphonyl-Gly-Pro-Ala, 250 mM Hepes pH 7.5, 400 mM NaCl, 10 mM CaCl 2 , 10 µM ZnCl 2 , and 2% DMSO. In case of poor compound solubility, the DMSO concentration was increased, but never exceeded 4.8%. The percentage of enzyme inhibition was calculated in relation to a reference without a compound added, only plus buffer control. For IC 50 measurements, the experiments were performed as described above, but using 10 nM ColH-PD, 2 µM FS1-1, 2% DMSO and employing 8 different compound concentrations. The compound concentrations were chosen to be evenly distributed above and below the estimated IC 50 . All experiments were performed in triplicates and repeated at least three times. IC 50 values were determined using non-linear regression with a constant Hill slope of -1. In case of tight binding conditions (E T ≈ K i(app) ), the initial velocities were fit to the Morrison equation 5 . Enzyme concentration was held at a constant value E T = 10 nM (when K i (app) > E T ), whereas v 0 and K i(app) were treated as adjustable parameters 6 . IC 50 values are given as mean values of three independent experiments ± standard deviation. Reported apparent inhibition constants (K i(app) ) were measured under first-order conditions (S 0 << K M ) and with K i(app )/E T > 10 7 and in the presence of 3.5% DMSO. Measurements under reducing conditions were performed in the presence of 5 mM TCEP. Regression analysis was performed using GraphPad Prism 5 (Graph Pad Software, San Diego, CA, USA) and DYNAFIT (BioKin, Ltd.,
Madison, WI, USA).
Bacterial Collagenase Inhibition Assay. These assays were performed as described above for the IC 50 measurements using 100 µM of the indicated compounds. The final enzyme concentrations used were 10 nM ColH-PD, 30 nM ColT-PD, 40 nM ColG-CU, and 2 nM ColQ1-CU, respectively.
Human matrix metalloproteinases (MMP) inhibition assay.
The catalytic domains of MMP-1, -2, -3, -7, -8 and -14 along with the SensoLyte 520 Generic MMP Activity Kit were purchased from AnaSpec (Fremont, CA, USA). The assay was performed according to the guidelines of the manufacturer. Fluorescence signals were measured in a CLARIOstar plate reader (BMG LABTECH, Ortenberg, Germany) every 60 s for a period of 1 h. Compounds synthesized by us were tested at 100 µM. IC 50 values
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were determined for the hydroxamate-based peptidomimetic batimastat which was used as a positive control. The calculation of the IC 50 value was performed by plotting the percent inhibition vs. the different inhibitor concentrations on a semi-log plot. At least three independent measurements were performed for each compound. 
Isothermal Titration Calorimetry (ITC)
.
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tion giving a total run time of 5.5 min. The injection volume was 5 µL. The divert valve was set to 1.5 min. Before injecting samples the column was equilibrated with 10% methanol (v/v) in assay buffer using this method. Observed retention times were as follows: caffeine 2.29 min, cp. 3 2.68, cp. 12 3.08 min, cp. 7 3.22 min, cp. 13 3.00 min, cp. 14 3.57 min, cp. 15 3.52 min. Additional peaks were found at 3.51 min, 4.32 min and 4.19 min for cp. 13, 14 and 15, respectively, hinting at disulfide formation. Peak areas were determined using TF Xcalibur Software. Peak areas were normalized by ISTD peak area and divided by total peak area. Half-life was determined using a one-phase decay model (GraphPad Prism 5 software). 
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Chemistry. General Procedures. Compounds 2-12 and 21-37 were commercially available (ChemBridge, San Diego, CA, USA).
Synthesis of free thiols 13-15 was achieved by treating the respective anilines with thioglycolic acid in a neat reaction (see Scheme S1). 16 Selected thiocarbamates were synthesized according to the procedures described below.
Scheme S1. Synthesis of free thiol compounds 13-15.
All reagents were used from commercial suppliers without further purification. Procedures were not optimized regarding yield.
NMR spectra were recorded on a Bruker Fourier 300 (300 MHz) spectrometer. Chemical shifts are given in parts per million (ppm) and referenced against the residual proton, 1 H, or carbon, 13 C, resonances of the >99% deuterated solvents as internal Germany) or Chromabond Flash C 18 columns (Macherey-Nagel, Düren, Germany). Purity of compounds synthesized by us was determined by LCMS using the area percentage method on the UV trace recorded at a wavelength of 254 nm and found to be >95%. 
Thiol synthesis
N-(4-acetylphenyl)-2-mercaptoacetamide (13)
H
N-(2-chlorophenyl)-2-mercaptoacetamide (15)
2-chloroaniline (164 µL, 1.57 mmol) was placed in a crimp vial. The vial was evacuated and flushed with nitrogen three times, followed by addition of thioglycolic acid (120 µL, 1.72 mmol). The vial was flushed with argon and heated to 120°C for 5 hours. S17 N-(4-chlorophenyl)-2-mercaptoacetamide (14) was prepared according to the described procedure and the crude was taken in 6 mL THF without further workup or purification. Triethylamine (260 µL, 1.9 mmol) was added, followed by trimethylsilyl isocyanate (250 µL, 1.9 mmol). The reaction mixture was kept under argon atmosphere and refluxed for 5 hours. After cooling to room temperature the reaction was quenched for 10 min with methanol. O-anisidine (380 µL, 3.4 mmol) was added to a solution of chloroacetic acid (318 mg, 3.4 mmol) and ammonium thiocyanate (205 mg, 2.7 mmol) in 6 mL absolute ethanol. The reaction was refluxed for 1.5 hours until formation of a precipitate. Addition of water, followed by filtration gave the crude which was purified using automated flash chromatography (petroleum ether:ethyl acetate 80:20 to 0:100) to yield the title compound as a white powder (140 mg, 22% Methyl succinyl chloride (170 µL, 1.4 mmol) was added dropwise over 5 min to a solution of aniline (100 µL, 1.1 mmol) and triethylamine (300 µL, 2.2 mmol) in dry dichloromethane at 0 C. After another 5 min, the reaction was allowed to warm up to room temperature and was stirred for 3 hours. Washing with sodium bicarbonate solution and evaporation of the solvent gave the crude which was purified using radial thin-layer chromatography (dichloromethane) to yield methyl-4-oxo-4-(phenylamino)butanoate as a white powder (222 mg, 98%).
